Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Prepaid Assets (2020 - 2026)

Raphael Pharmaceutical's (RAPH) quarterly Prepaid Assets came in at $5000.0 in Q2 2026, down 37.5% year-over-year from $8000.0 in Q2 2025, and down 16.67% quarter-over-quarter from $6000.0 in Q4 2025.

Analysis

Raphael Pharmaceutical (RAPH) Prepaid Assets (2020 - 2026) Analysis & Trends

Raphael Pharmaceutical has disclosed Prepaid Assets across 7 years of filings, most recently posting $5000.0 for Q2 2026.

  • In Q2 2026, Prepaid Assets fell 37.5% year-over-year to $5000.0; the TTM figure through Jun 2026 stood at $5000.0 (down 37.5% YoY), while the FY2025 annual figure was $6000.0, changed 0.0% from the prior year.
  • Prepaid Assets came in at $5000.0 for Q2 2026 at Raphael Pharmaceutical, down from $6000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $111000.0 in Q1 2023 to a low of $2000.0 in Q3 2025.
  • Average Prepaid Assets over 5 years is $35470.6, with a median of $9000.0 recorded in 2024.
  • Year-over-year, Prepaid Assets soared 296.15% in 2023 and sank 91.26% in 2024.
  • Over 5 years, Prepaid Assets stood at $43000.0 in 2022, then slumped by 83.72% to $7000.0 in 2023, then fell by 14.29% to $6000.0 in 2024, then changed by 0.0% to $6000.0 in 2025, then dropped by 16.67% to $5000.0 in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $5000.0 in Q2 2026, $6000.0 in Q4 2025, and $2000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Raphael Pharmaceutical 28.25 Mn 28.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5,000.00
Dec 31, 2025 6,000.00
Sep 30, 2025 2,000.00
Jun 30, 2025 8,000.00
Mar 31, 2025 41,000.00
Dec 31, 2024 6,000.00
Sep 30, 2024 9,000.00
Jun 30, 2024 6,000.00
Mar 31, 2024 63,000.00
Dec 31, 2023 7,000.00
Sep 30, 2023 103,000.00
Jun 30, 2023 7,000.00
Mar 31, 2023 111,000.00
Dec 31, 2022 43,000.00
Sep 30, 2022 26,000.00
Jun 30, 2022 61,000.00
Mar 31, 2022 99,000.00
Dec 31, 2021 269,000.00
Sep 30, 2021 25,000.00
Dec 31, 2020 228,000.00